Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001193125-26-076544 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-02-26 | 2026-02-24 | BEAM | Ciaramella Giuseppe | Pres | M - OptEx | $17.00 | +35.0K | 225.2K | +18% | +$595.0K |
| DT | 2026-02-26 | 2026-02-24 | BEAM | Ciaramella Giuseppe | Pres | S - Sale+OE | $32.00 | -35.0K | 190.2K | -16% | -$1.12M |
| DT | 2026-02-26 | 2026-02-24 | BEAM | Ciaramella Giuseppe | Pres | M - OptEx | $0.00 | -35.0K | 397.3K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | M | A | 35,000 | $17.00 | 225,216 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-24 | S | D | 35,000 | $32.00 | 190,216 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $32.00 to $32.04, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-02-24 | M | D | 35,000 | $0.00 | 397,313 | D | $17.00 · — to 2030-02-05 | 35,000 Common Stock | (F3) The option vests as to 25% on the first anniversary of the of the vesting commencement date, February 5, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested. |